Natty Greene's  Instablog

Natty Greene
Send Message
Natty Greene is an avid investor who is always on the hunt for undiscovered small cap gems benefitting from secular growth trends with an eye toward those stocks with increased insider or institutional ownership and potential acquisition targets.
  • ACUR News: Top 3 National Drug Wholesalers To Distribute Acura's NEXAFED 7 comments
    Apr 18, 2013 9:31 AM | about stocks: ACUR

    Acura Pharmaceuticals (NASDAQ:ACUR) has not yet released this specific information in the form of a press release, but I would expect they will soon in some form (currently just up on new NEXAFED website).

    This is big news!

    My research just uncovered that Acura has reached distribution agreements with the top three national drug wholesalers (McKesson, Cardinal Health, and Amerisource Bergen) and these big three are now distributing Acura's NEXAFED pseudoephedrine tablets to retail drug stores all over the country.

    This is extremely significant because these big three represent 85% of all U.S. drug wholesale revenue. These distributors have now given Acura's NEXAFED a national reach that goes well beyond the recently announced direct partnership with drug store chain Kerr Drugs.

    Acura has also reached agreement with the the 4th, 5th, 6th, and 7th largest drug wholesale distributors (Morris & Dickson, H.D. Smith, Smith Drug, and NC Mutual Drug) to sale NEXAFED too.

    Most have probably missed this big NEXAFED news due to the focus on the recent FDA ruling on OxyContin and the bullish ramifications for Acura's other AVERSION tamper resistant technology for opioid analgesics.

    About Nexafed®

    Nexafed® [pseudoephedrine hydrochloride (HCl)] is a 30 mg immediate-release abuse-deterrent decongestant. The next generation pseudoephedrine tablet combines effective nasal-congestion relief with Impede™ technology, a unique polymer matrix that disrupts the conversion of pseudoephedrine into the dangerous drug, methamphetamine. Specifically, the Impede™ technology forms a thick gel when the tablets are dissolved in solvents typically used in the pseudoephedrine extraction or methamphetamine production processes, trapping the pseudoephedrine or converted methamphetamine to prevent its isolation or purification.

    Disclosure: I am long ACUR.

    Stocks: ACUR
Back To Natty Greene's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (3)
Track new comments
  • Adam Gefvert, CFA
    , contributor
    Comments (1448) | Send Message
     
    Thanks. How old are those distribution agreements?
    18 Apr 2013, 10:09 AM Reply Like
  • DWD Investing
    , contributor
    Comments (13055) | Send Message
     
    Why don't they release this information on the ACUR website? This is great news.

     

    Where exactly is the documents showing they actually have contracts?
    28 Apr 2013, 10:09 PM Reply Like
  • forever_opimistic
    , contributor
    Comments (104) | Send Message
     
    Nexafed is now for sale at Kroger retail pharmacies. Check the Nexafed website, search Cincinnati 50 mile radius. You will see 8 retail locations carrying Nexafed.

     

    I purchased some yesterday at one of those stores.
    6 May 2013, 03:36 AM Reply Like
  • DWD Investing
    , contributor
    Comments (13055) | Send Message
     
    Did you try to shake and bake it? lol
    9 May 2014, 03:19 PM Reply Like
  • Jbgoose
    , contributor
    Comments (3067) | Send Message
     
    If only they would hire an ad agency for a more traditional product campaign? The pharmacist already knows the situation; the consumer is inconvenienced enough as is. They need to see a happy couple running through a field of allergens or a cartoon character of an irritated nose? It's ok to smile once in a while.

     

    Good luck brave shareholders.
    8 May 2014, 03:47 PM Reply Like
  • PharmSterZzZ
    , contributor
    Comments (253) | Send Message
     
    nobody is going to buy ZGNX....every time someone writes something about a buyout, then it will never happen

     

    if there is a buyout, then the company will tell people to ZIP their mouth..no media..no nothing...then they're going to announce good news.....

     

    Nobody is going to buy zgnx..forget it...but i am long on this stock....PT 5 IN 2016...FORGET about buyout....
    2 Feb 2015, 11:03 PM Reply Like
  • Jbgoose
    , contributor
    Comments (3067) | Send Message
     
    PharmSterZzZ / buzz kill about ZGNX ... JNJ got rid of Nucynta ER ! Which could be a novel remedy for many until one reads about potential side effects within a population that are already at risk. So the real target population is less than it could be yet it looked large enough to sell off. But who am I to crash the party. I do like the Tiger logo they have on marketing materials. No comments on ACUR. Per most NatGeo or Discovery crime show that tracks mountains of pure meth from factory to everywhere. It's horrible, yes. But not on the general populations mind and the scare tactics used will never work. More returned product than stocked product I guess. Was it all just a very big grant for a few research docs?
    3 Feb 2015, 02:36 PM Reply Like
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.